NGL Fine Chem Share Price

₹ 2,551.90

+₹25.90 (1.03%)
1D
Last updated 02 Nov, 2026, 15:29 IST
NSE: NGLFINE
|
Pharmaceuticals

NGL Fine Chem Share Price Today

As of 3 Nov 2026, NGL Fine Chem share price is ₹2,551.90. The stock opened at ₹2,543.00, compared to its previous close of ₹2,526.00. During today's trading session, NGL Fine Chem share price moved in the range of ₹2,516.90 to ₹2,579.90, with an average price of ₹2,548.40 for the day. Looking at its last 52-week, the stock has touched a low of ₹1,271.00 and a high of ₹3,602.00. On the performance front, NGL Fine Chem share price has increased by 14.47% over the last six months and is up 68.51% on a year-on-year basis.

Share price over the last 1 day rose from 2539.00 to 2551.90, ranging between 2520.10 and 2574.00.

₹2,516.90
1.03% up today
₹2,579.90
1D LOW
1D HIGH

NGL Fine Chem Stock Insights

Latest Earning
Op Profit TrendUp by 37.45% QoQ
Latest Earning
Net Profit TrendUp by 36.40% QoQ
Latest Earning
Revenue TrendUp by 36.83% YoY
Stock Performance
OutperformingBeat Nifty by 16.23 % in last 6 month
Shareholding Pattern
DIIDII decreased stake by 100.00%
Shareholding Pattern
FIIFII decreased stake by 9.50%
NGL Fine Chem stock performance
Open₹2,543.00
High₹2,579.90
Low₹2,516.90
Prev. close₹2,526.00
NGL Fine Chem trading activity
Volume2,841
Average traded price₹2,546.03
Last traded time03:29:32 02 Nov
Last traded quantity1

Circuit
L
H
₹2,028.00
₹3,041.80
52-week
L
H
₹1,271.00
₹3,602.00
Mkt Cap Cr
1,576.55

P/E
27.56

P/B
4.79

ROA
10.49%
ROE
14.62%

ROCE
15.37%

Quick Ratio
1.37

EV/EBITDA
16.66

Based on fundamentals, this stock's

Performance: 1 out of 5, Very Poor
Performance
Very Poor
NGL Fine Chem has not beaten FD return of 7%
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
NGL Fine Chem appears overvalued compared to its peers
Earnings: 5 out of 5, Excellent
Earnings
Excellent
NGL Fine Chem revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,26,661.7438.834.789.61%13.79%18.65%2.3122.27
Divis Laboratories2,57,902.7388.1715.3914.6%15.32%19.56%3.558.97
Torrent Pharmaceuticals1,74,402.4783.099.494.7%11.42%11.37%0.7533.6
Laurus Labs1,26,811.2895.1720.9211.58%22.11%20.91%0.6854.77
Zydus Lifesciences1,24,089.4827.024.588.57%18.59%17.35%0.9116.42
Dr. Reddy's Laboratories1,12,698.5340.842.94.79%7.21%8.58%1.3519.05
Cipla1,11,486.1439.063.156.6%8.18%10.8%2.521.03
Mankind Pharma1,02,796.6045.425.857.82%12.76%14.68%0.7425.01
Aurobindo Pharma96,536.9026.022.556.34%9.25%11.76%1.1512.38
Lupin91,870.1616.554.0914.47%23.76%24.88%1.429.83

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

NGL Fine Chem Company Background

ISIN
INE887E01022
Sector Market Cap
₹ 1,576.55 Cr

NGL Fine-Chem Limited is an India-based company, which is a manufacturer of pharmaceuticals and intermediates for use in veterinary and human health. The Company caters to various global companies to custom manufacture pharmaceuticals. Its products include APIs Animal Health, APIs Human Health, Intermediates and Specialty Chemicals and Finished Dosage Form. The APIs Animal Health products include Homidium Chloride, Nitroxynil, Clorsulon, Parvaquone, Buparvaquone, Isometamidium Chloride Hydrochloride, Toldimfos Sodium, Butaphosphan, Imidocarb Dipropionate, Triclabendazole, Rafoxanide, Diminazene Aceturate, S-Methoprene, Carprofen and others. The APIs Human Health products include Nitazoxanide and Atovaquone. The Intermediates and Specialty Chemicals product includes 1,4,7-Trimethyl-1,4,7-Triazacylononane and N-Ethyl Glucamine. The Finished Dosage Form products include Diminazene Aceturate Granules and Homidium Chloride Tablets. It has manufacturing plants located around Mumbai.

NGL Fine Chem Financial Highlights

  • Revenue: NGL Fine Chem reported revenue of ₹515.68 crore in FY26 vs ₹376.89 crore in FY25. It showed an increase of 36.83% on a yearly basis.
  • Operating Profit: NGL Fine Chem reported an operating profit of ₹63.37 crore in FY26 vs ₹27.71 crore in FY25. It showed an increase of 128.69% on a year-on-year basis.
  • Net Profit: NGL Fine Chem reported a net profit of ₹48.13 crore in FY26 vs ₹21.12 crore in FY25. It showed an increase of 127.89% on a yearly basis.

NGL Fine Chem Quarterly Result Highlights

  • NGL Fine Chem reported revenue of ₹146.59 crore in Jun 2026, compared with ₹151.69 crore in Mar 2026, representing a decrease of 3.36% on a quarter-on-quarter (QoQ) basis.
  • NGL Fine Chem reported an operating profit of ₹24.48 crore in Jun 2026, compared with ₹17.81 crore in Mar 2026, representing an increase of 37.45% on a quarter-on-quarter (QoQ) basis.
  • NGL Fine Chem reported a profit of ₹18.40 crore in Jun 2026, compared with ₹13.49 crore in Mar 2026, reflecting an increase of 36.40% on a QoQ basis.
  • The earnings per share (EPS) of NGL Fine Chem stood at ₹77.90 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
72.49%
FII
0.04%
Other DII
0.00%
Retail and other
27.46%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 20250.00%
Mar 20260.03%
Jun 20260.05%
Sep 20260.04%

NGL Fine Chem Investment Returns

1 day
+0.35%

1 week
-3.40%

1 month
-13.31%

1 year
+68.51%

3 years
+39.35%

5 years
+35.63%

NGL Fine Chem Share Price History

NGL Fine Chem share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
02 Nov 26
₹2,543.00 / ₹2,534.90
+0.35%
30 Oct 26
₹2,615.10 / ₹2,526.00
-3.32%
29 Oct 26
₹2,633.60 / ₹2,612.80
+0.08%
28 Oct 26
₹2,614.50 / ₹2,610.60
-0.83%
Show more

NGL Fine Chem Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹500.95₹368.26₹338.69₹278.08
Other Income₹14.73₹8.63₹14.13₹5.53
Total Revenue₹515.68₹376.89₹352.82₹283.61
Total Expenses₹452.32₹349.17₹298.40₹256.25
Profit Before Tax₹63.37₹27.71₹54.42₹27.36
Tax₹15.24₹6.59₹13.10₹6.87
Profit After Tax₹48.13₹21.12₹41.32₹20.50
EPS - Basic₹77.90₹34.19₹66.88₹33.18
EPS - Diluted₹77.90₹34.19₹66.88₹33.18

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹63.37₹27.71₹54.42₹27.36
Income before WC changes₹89.22₹40.83₹66.18₹38.89
Change in Assets-₹59.57-₹20.35-₹59.03₹16.05
Change in Liabilities₹28.91₹18.46₹26.41-₹12.79
Change in WC-₹30.66-₹1.89-₹32.62₹3.26
Cash flow from Operations₹43.32₹32.35₹20.47₹35.29
Cash flow from Investing-₹70.59-₹69.68-₹26.82-₹27.02
Cash flow from Financing₹29.55₹37.47-₹1.08-₹1.08
Total Cash Flow₹2.27₹0.14-₹7.43₹7.18
Cash (Start of the year)₹0.53₹0.40₹7.83₹0.64
Cash (End of the year)₹2.81₹0.53₹0.40₹7.83

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹269.11₹200.80₹142.87₹124.42
Current Assets₹276.39₹233.88₹212.67₹162.66
Total Assets₹545.50₹434.68₹355.54₹287.08
Current Liabilities₹150.01₹118.42₹86.59₹58.29
Net Current Asset₹126.38₹115.46₹126.08₹104.36
Non-Current Liabilities₹66.25₹33.83₹6.32₹6.24
Equity Capital₹329.24₹282.43₹262.63₹222.55
Total Equity & Liabilities₹545.50₹434.68₹355.54₹287.08

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹488.77₹359.29₹328.97₹275.05
Other Income₹14.85₹9.76₹15.90₹7.61
Total Revenue₹503.63₹369.05₹344.87₹282.66
Total Expenses₹449.01₹345.17₹294.17₹256.07
Profit Before Tax₹54.62₹23.88₹50.71₹26.60
Tax₹12.99₹5.75₹12.19₹6.48
Profit After Tax₹41.63₹18.13₹38.52₹20.12
EPS - Basic₹67.39₹29.35₹62.35₹32.57
EPS - Diluted₹67.39₹29.35₹62.35₹32.57

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹54.62₹23.88₹50.71₹26.60
Income before WC changes₹76.55₹32.59₹49.58₹32.51
Change in Assets-₹57.02-₹21.72-₹51.94₹18.04
Change in Liabilities₹28.19₹16.87₹25.68-₹12.18
Change in WC-₹28.83-₹4.85-₹26.26₹5.86
Cash flow from Operations₹34.73₹21.99₹11.14₹31.89
Cash flow from Investing-₹64.57-₹58.20-₹17.49-₹23.62
Cash flow from Financing₹29.87₹36.35-₹1.08-₹1.08
Total Cash Flow₹0.03₹0.14-₹7.44₹7.19
Cash (Start of the year)₹0.52₹0.39₹7.82₹0.64
Cash (End of the year)₹0.55₹0.52₹0.39₹7.82

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹264.38₹198.20₹149.35₹128.92
Current Assets₹265.25₹227.56₹203.69₹159.19
Total Assets₹529.63₹425.76₹353.05₹288.11
Current Liabilities₹144.03₹112.96₹84.36₹56.65
Net Current Asset₹121.22₹114.60₹119.33₹102.54
Non-Current Liabilities₹65.66₹33.19₹5.88₹5.94
Equity Capital₹319.94₹279.61₹262.81₹225.52
Total Equity & Liabilities₹529.63₹425.76₹353.05₹288.11
* All values are in INR Crore
NGL Fine Chem market depth
Bid quantityBid priceAsk priceAsk quantity
252534.900
0000
0000
0000
0000
Total bid quantity25
Total ask quantity0
NGL Fine Chem technical summary
Bearish indicators2
Neutral indicators3
Bullish indicators3
OverallSlightly Bullish
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict

RSI (14)
31.28
Neutral

ATR (14)
115.39
Neutral

STOCH(9,6)
20.19
Bullish

STOCH RSI (14)
0
Bullish

ADX(9)
42.01
Bearish

UO(9)
46.89
Neutral

ROC(12)
-12.21
Bearish

WillR(14)
-85.36
Bullish
Period
Simple value
Exponential vaue

5D
2601.2
2596.98

10D
2647.86
2653.87

20D
2801.18
2728.4

50D
2808.93
2824.39

100D
2983.01
2829.37
Volume trend — traded volume by day
2 Nov0L
30 Oct0L
29 Oct0L
28 Oct0L
27 Oct0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

NGL Fine Chem
Pharmaceuticals
Add Stock
Add Another

NGL Fine Chem Returns Calculator

Ex-date: 18 Aug 2026

NGL Fine Chem Share Price FAQs












Please be aware that NGL Fine Chem stock prices are subject to continuous fluctuations due to various factors.